 | Up a level |
Haensli, Christof; Pfister, Isabel B; Garweg, Justus G (2021). Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes. Journal of clinical medicine, 10(12) MDPI 10.3390/jcm10122666
